Cambridge, Mass., October 21, 2014 – Voyager Therapeutics, a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS), will today celebrate the opening of its new headquarters with a ribbon cutting ceremony and open house. Voyager’s new headquarters, located at 75 Sidney Street in Cambridge, features state-of-the-art research and process development laboratories.
(left to right) Steven Paul, M.D., President & CEO of Voyager Therapeutics; Susan Windham-Bannister, Ph.D., President & CEO of the Massachusetts Life Sciences Center (MLSC); Mark Levin, Partner at Third Rock Ventures and Chairman of Voyager Therapeutics; Terry Flotte, M.D., Dean of the University of Massachusetts Medical School; Michael Collins, M.D., Chancellor of the University of Massachusetts Medical School; and Guangping Gao, Ph.D. Professor, Microbiology and Physiology Systems &Penelope Booth Rockwell Chair in Biomedical Research & Director, Gene Therapy Center and Vector Core Scientific Director, UMMS-China Program celebrate the opening of Voyager Therapeutics new headquarters in Cambridge, Massachusetts.